Roche: Genentech Offers Up To $765M in Biobucks to Repertoire for I&I Drug Discovery
Roche's Genentech is betting on the Flagship Pioneering-founded company's discovery platform called DECODE to find new targets for an undisclosed autoimmune disorder.
Read full article »
Roche is a Switzerland-based biotechnology company that discovers, develops, and provides diagnostic and pharmaceutical products and services for the healthcare sector.
Read more